September 06, 2022
1 min read
Save
Revelle gains extended FDA clearance for cellulite release device
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The cellulite release device Avéli has gained extended FDA clearance for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of women, Revelle Aesthetics announced in a press release.
The Avéli device is used in a minimally invasive procedure that allows identification of fibrous septa bands that cause cellulite dimples as well as confirmation in real-time that those targeted septa are being released, according to the release.
“[W]e believe Avéli will play a role as a cornerstone in the latest and fastest growing category in medical aesthetics, lower body rejuvenation,” Caroline Van Hove president and CEO of Revelle Aesthetics, said in the release.